A carregar...

Growth Hormone Decreases Visceral Fat and Improves Cardiovascular Risk Markers in Women with Hypopituitarism: A Randomized, Placebo-Controlled Study

Context: Data regarding gender-specific efficacy of GH on critical endpoints are lacking. There are no randomized, placebo-controlled studies of physiological GH therapy solely in women. Objective: Our objective was to determine the effects of physiological GH replacement on cardiovascular risk mark...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Beauregard, Catherine, Utz, Andrea L., Schaub, Amber E., Nachtigall, Lisa, Biller, Beverly M. K., Miller, Karen K., Klibanski, Anne
Formato: Artigo
Idioma:Inglês
Publicado em: The Endocrine Society 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2435650/
https://ncbi.nlm.nih.gov/pubmed/18381581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2007-2371
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!